Article Sidebar

PDF
Date Published: 28/01/2023
Abstract Views: 401
Views PDF: 414
DOI: https://doi.org/10.56535/jmpm.v48i1.238
Issue
Vol. 48 No. 1 (2023): TẠP CHÍ Y DƯỢC HỌC QUÂN SỰ SỐ 1 - 2023
Section
Articles
How to Cite
Ta, B. T., & Đào, N. B. (2023). UPDATE OF METHODS FOR EARLY DIAGNOSIS OF LUNG CANCER. Journal of Military Pharmaco-medicine, 48(1), 50-62. https://doi.org/10.56535/jmpm.v48i1.238

UPDATE OF METHODS FOR EARLY DIAGNOSIS OF LUNG CANCER

Ta Ba Thang, Ngọc Bằng Đào1,
1 Trung tâm Nội Hô hấp, Bệnh viện Quân y 103

Main Article Content

Abstract

Lung cancer is one of the most common cancers and the leading cause of cancer death worldwide. Early diagnosis plays a very important role in deciding treatment therapy and prognosis for patients with lung cancer. Many methods have been applied in the early diagnosis of lung cancer, in which thoracic low-dose computed tomography (LDCT), bronchoscopy, and molecular biology methods have proven remarkable effects. Each diagnostic technique has its own role. While bronchoscopy with biopsy is used to diagnose central bronchial lesions, LDCT can be applied to screen for tumors in the peripheral bronchi, which could not be observed by bronchoscopy. In addition, liquid biopsy using malecular biomarkers is a potential measure. The combination of diagnostic measures will help clinicians to diagnose lung cancer early, assign reasonable treatment methods and make accurate prognosises for patients, contributing to improving the effectiveness of lung cancer treatment in clinical practice.

Article Details

Keywords

Non-small cell lung cancer, Low-dose computed tomography, Diagnostic bronchoscopy, Liqid biopsy

References

1. Sung H., Ferlay J., Siegel R.L. (2021). Global Cancer Statistics 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Ca Cancer J Clin; 71:209-224.
2. Globocan (2020). Viet Nam - Global Cancer Observatory.
3. Ettinger D.S., Wood D.E., Aisner D.L., et al. (2020). Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw; 20(5): 497-530.
4. American Cancer Society (2017). Cancer Facts and Figures 2017; 19-21.
5. Larke F.J., Kruger R.L., Cagnon C.H., et al. (2011). Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial. AJR Am J Roentgenol; 197(5): 1165-1169.
6. Chiles C. (2014). Lung Cancer Screening with Low Dose CT. Radiol Clin North Am; 52(1): 27-46.
7. National Lung Screening Trial Research Team (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med; 365(5): 395-409.
8. Cruickshank A., Stieler G., Ameer F. (2019). Evaluation of the solitary pulmonary nodule. Internal Medicine Journal; 49(3): 283-412.
9. MacMahon H., Naidich D.P., Goo J.M., et al. (2017). Guidelines for Management of incidental nodules detected on CT images: From the Fleischner Society 2017. Radiology; 284(1): 228-243.
10. Wender R., Fontham E.T.H., Barrera E. Jr, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin; 63(2): 106-117.
11. Andolfi A., Potenza R., Capozzi R., et al. (2016). The role of bronchoscopy in the diagnosis of early lung cancer: A review. J Thorac Dis; 8(11): 3329-3337.
12. Zaric B., Perin B., Carapic B., et al. (2012). Diagnostic value of autofluorescence bronchoscopy in lung cancer. Thoracic Cancer.
13. Zhu J., Li W., Zhou J., et al. (2017). The diagnostic value of narrow-band imaging for early and invasive lung cancer: a meta-analysis. Clinics (Sao Paulo); 72(7): 438-448.
14. Shibuya K., Hoshino H., Chiyo M., et al. (2002). Subepithelial vascular patterns in bronchial dysplasias using a high magnification bronchovideoscope. Thorax; 57: 902-907.
15. Muriana P. and Rossetti F. (2020). The role of EBUS-TBNA in lung cancer restaging and mutation analysis. Mediastinum; 4:23.
16. Freitas C., Sousa C., Machado F., et al. (2021). The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer. Front Oncol; 11: 634316.